Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole

Molecular Microbiology

Volumn 47, Issue 2, 2003, Pages 357-371

  Posteraro, Brunella ^a   Sanguinetti, Maurizio ^a   Sanglard, Dominique ^b   La Sorda, Marilena ^a   Boccia, Stefania ^a   Romano, Lucio ^a   Morace, Giulia ^c   Fadda, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM MUTANT; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; GENE IDENTIFICATION; GENE ISOLATION; GENE OVEREXPRESSION; HYBRIDIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CLONING, MOLECULAR; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FUNGAL PROTEINS; GENE DELETION; GENE LIBRARY; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; SEQUENCE ALIGNMENT;

BACTERIA (MICROORGANISMS); FILOBASIDIELLA NEOFORMANS;

EID: 0037238468     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.2003.03281.x     Document Type: Article

References (86)

1. Aller, A.I., Martin-Mazuelos, E., Lozano, F., Gomez-Mateos, J., Steele-Moore, L., Holloway, W.J., et al. (2000) Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob Agents Chemother 44: 1544-1548.
2. Ammassari, A., Linzalone, A., Murri, R., Marasca, G., Morace, G., and Antinori, A. (1995) Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case-control study. Scand J Infect Dis 27: 235-237.
3. Andrade, A.C., Del Sorbo, G., Van Nistelrooy, J.G., and Waard, M.A. (2000) The ABC transporter AtrB from Aspergillus nidulans mediates resistance to all major classes of fungicides and some natural toxic compounds. Microbiology 146: 1987-1997.
4. Armengou, A., Porcar, C., Mascaro, J., and Garcia-Bragado, F. (1996) Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis 23: 1337-1338.
5. Avery, S.V., Malkapuram, S., Mateus, C., and Babb, K.S. (2000) Copper/zinc-Superoxide dismutase is required for oxytetracycline resistance of Saccharomyces cerevisiae. J Bacteriol 182: 76-80.
6. Balan, I., Alarco, A.M., and Raymond, M. (1997) The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter. J Bacteriol 179: 7210-7218.
7. Balzi, E., Wang, M., Leterme, S., Van Dyck, L., and Goffeau, A. (1994) PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J Biol Chem 269: 2206-2214.
8. Bammert, G.F., and Fostel, J.M. (2000) Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob Agents Chemother 44: 1255-1265.
9. Barchiesi, F., Calabrese, D., Sanglard, D., Falconi Di Francesco, L., Caselli, F., Giannini, D., et al. (2000) Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 44: 1578-1584.
10. Birley, H.D., Johnson, E.M., McDonald, P., Parry, C., Carey, P.B., and Warnock, D.W. (1995) Azole drug resistance as a cause of clinical relapse in AIDS patients with cryptococcal meningitis. Int J STD AIDS 6: 353-355.
11. Bogush, M.L., Velikodvorskaya, T.V., Lebedev, Y.B., Nikolaev, L.G., Lukyanov, S.A., Fradkov, A.F., et al. (1999) Identification and localization of differences between Escherichia coli and Salmonella typhimurium genomes by suppressive subtractive hybridization. Mol Gen Genet 262: 721-729.
12. Casadevall, A., and Perfect, J.R. (1998) Cryptococcus neoformans. Washington: American Society for Microbiology Press.
13. Chaturvedi, S., Hamilton, A.J., Hobby, P., Zhu, G., Lowry, C.V., and Chaturvedi, V. (2001) Molecular cloning, phylogenetic analysis and three-dimensional modeling of Cu,Zn superoxide dismutase (CnSOD1) from three varieties of Cryptococcus neoformans. Gene 268: 41-51.
14. Clark, F.S., Parkinson, T., Hitchcock, C.A., and Gow, N.A. (1996) Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. Antimicrob Agents Chemother 40: 419-425.
15. Cox, G.M., Rude, T.H., Dykstra, C.C., and Perfect, J.R. (1995) The actin gene from Cryptococcus neoformans: structure and phylogenetic analysis. J Med Vet Mycol 33: 261-266.
16. Cox, G.M., Toffaletti, D.L., and Perfect, J.R. (1996) Dominant selection system for use in Cryptococcus neoformans. J Med Vet Mycol 34: 385-391.
17. Cox, G.M., McDade, H.C., Chen, S.C., Tucker, S.C., Gottfredsson, M., Wright, L.C. et al. (2001) Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 39: 166-175.
18. Davey, K.J., Johnson, E.M., Holmes, A.D., Szekely, A., and Warnock, D.W. (1997) Emergence of drug resistant Cryptococcus neoformans strains during maintenance fluconazole treatment in AIDS patients, Abstract. P493. Proceedings of the International Society of Human and Animal Mycology.
19. Decottignies, A., and Goffeau, A. (1997) Complete inventory of the yeast ABC proteins. Nat Genet 15: 137-145.
20. Diatchenko, L., Lau, Y.F., Campbell, A.P., Chenchik, A., Moqadam, F., Huang, B., et al. (1996) Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93: 6025-6030.
21. Diatchenko, L., Lukyanov, S., Lau, Y.F., and Siebert, P.D. (1999) Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes. Methods Enzymol 303: 349-380.
22. Fischli, A., Schmid, S.R., Coppolecchia, R., and Linder, P. (1996) The translation initiation factor eIF-4A from Schizosaccharomyces pombe is closely related to its mammalian counterpart. Yeast 12: 977-981.
23. Franz, R., Kelly, S.L., Lamb, D.C., Kelly, D.E., Ruhnke, M., and Morschhauser, J. (1998) Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 42: 3065-3072.
24. Friese, G., Discher, T., Fussle, R., Schmalreck, A., and Lohmeyer, J. (2001) Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease. AIDS 15: 2344-2345.
25. Gao, B., Allen, R., Maier, T., Davis, E.L., Baum, T.J., and Hussey, R.S. (2001) Identification of putative parasitism genes expressed in the esophageal gland cells of the soybean cyst nematode Heterodera glycines. Mol Plant Microbe Interact 14: 1247-1254.
26. Geber, A., Hitchcock, C.A., Swartz, J.E., Pullen, F.S., Marsden, K.E., Kwon-Chung, K.J., et al. (1995) Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob Agents Chemother 39: 2708-2717.
27. Gingras, M.C., and Margolin, J.F. (2000) Differential expression of multiple unexpected genes during U937 cell and macrophage differentiation detected by suppressive subtractive hybridization. Exp Hematol 28: 65-76.
28. Hufton, S.E., Moerkerk, P.T., Brandwijk, R., de Bruine, A.P., Arends, J.W., and Hoogenboom, H.R. (1999) A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett 463: 77-82.
29. Janbon, G., Himmelreich, U., Moyrand, F., Improvisi, L., and Dromer, F. (2001) Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. Mol Microbiol 42: 453-467.
30. Janke, B., Dobrindt, U., Hacker, J., and Blum-Oehler, G. (2001) A subtractive hybridisation analysis of genomic differences between the uropathogenic E. coli strain 536 and the E. coli K-12 strain MG1655. FEMS Microbiol Lett 199: 61-66.
31. Jessup, C.J., Pfaller, M.A., Messer, S.A., Zhang, J., Tumberland, M., Mbidde, E.K., et al. (1998) Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients. J Clin Microbiol 36: 2874-2876.
32. Johnsson, A., Zeelenberg, I., Min, Y., Hilinski, J., Berry, C., Howell, S.B., et al. (2000) Identification of genes differentially expressed in association with acquired cisplatin resistance. Br J Cancer 83: 1047-1054.
33. Johnsson, A., Byrne, P., Bruin, R., Weiner, D., Wong, J. and Los, G. (2001) Identification of gene clusters differentially expressed during the cellular injury responses (CIR) to cisplatin. Br J Cancer 85: 1206-1210.
34. Joseph-Horne, T., Hollomon, D., Loeffler, R.S., and Kelly, S.L. (1995) Cross-resistance to polyene and azole drugs in Cryptococcus neoformans. Antimicrob Agents Chemother 39: 1526-1529.
35. Joseph-Horne, T., Loeffler, R.S., Hollomon, D.W., and Kelly, S.L. (1996) Amphotericin B resistant isolates of Cryptococcus neoformans without alteration in sterol biosynthesis. J Med Vet Mycol 34: 223-225.
36. Kolaczkowski, M., van der Rest, M., Cybularz-Kolaczkowska, A., Soumillion, J.P., Konings, W.N., and Goffeau, A. (1996) Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J Biol Chem 271: 31543-31548.
37. Kuang, W.W., Thompson, D.A., Hoch, R.V., and Weigel, R.J. (1998) Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res 26: 1116-1123.
38. Lamb, D.C., Corran, A., Baldwin, B.C., Kwon-Chung, J., and Kelly, S.L. (1995) Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients. FEBS Lett 368: 326-330.
39. Larose, M., Bouchard, C., and Chagnon, Y.C. (2001) A new gene related to human obesity identified by suppression subtractive hybridization. Int J Obes Relat Metab Disord 25: 770-776.
40. Lee, K.F., Kwok, K.L., and Yeung, W.S. (2000) Suppression subtractive hybridization identifies genes expressed in oviduct during mouse preimplantation period. Biochem Bio-phys Res Commun 277: 680-685.
41. Linder, P., and Slonimski, P.P. (1988) Sequence of the genes TIF1 and TIF2 from Saccharomyces cerevisiae coding for a translation initiation factor. Nucleic Acids Res 16: 10359.
42. Lopez-Ribot, J.L., McAtee, R.K., Lee, L.N., Kirkpatrick, W.R., White, T.C., Sanglard, D., et al. (1998) Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 42: 2932-2937.
43. Lyons, C.N., and White, T.C. (2000) Transcriptional analyses of antifungal drug resistance in Candida albicans. Antimicrob Agents Chemother 44: 2296-2303.
44. Mannhaupt, G., Stucka, R., Ehnle, S., Vetter, I., and Feldmann, H. (1994) Analysis of a 70kb region on the right arm of yeast chromosome II. Yeast 10: 1363-1381.
45. McDade, H.C., and Cox, G.M. (2001) A new dominant selectable marker for use in Cryptococcus neoformans. Med Mycol 39: 151-154.
46. Miyazaki, H., Miyazaki, Y., Geber, A., Parkinson, T., Hitchcock, C., Falconer, D.J., et al. (1998) Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob Agents Chemother 42: 1695-1701.
47. Moran, G.P., Sullivan, D.J., Henman, M.C., McCreary, C.E., Harrington, B.J., Shanley, D.B., et al. (1997) Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 41: 617-623.
48. Nakaune, R., Adachi, K., Nawata, O., Tomiyama, M., Akutsu, K., and Hibi, T. (1998) A novel ATP-binding cassette transporter involved in multidrug resistance in the phytopathogenic fungus Penicillium digitatum. Appl Environ Microbiol 64: 3983-3988.
49. National Committee for Clinical Laboratory Standards (1997) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Approved standard NCCLS document M27-A. National Committee for Clinical Laboratory Standards: Wayne, PA.
50. Nolte, F.S., Parkinson, T., Falconer, D.J., Dix, S., Williams, J., Gilmore, C., et al. (1997) Isolation and characterization offluconazole- and amphotericin B-resistant Candida albi-cans from blood of two patients with leukemia. Antimicrob Agents Chemother 41: 196-199.
51. Paugam, A., Dupouy-Camet, J., Blanche, P., Gangneux, J.P., Tourte-Schaefer, C., and Sicard, D. (1994) Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clin Infect Dis 19: 975-976.
52. Peetermans, W., Bobbaers, H., Verhaegen, J., and Vandepitte, J. (1993) Fluconazole-resistant Cryptococcus neoformans var. gattii in an AIDS patient. Acta Clin Belg 48: 405-409.
53. Perea, S., Lopez-Ribot, J.L., Kirkpatrick, W.R., McAtee, R.K., Santillan, R.A., Martinez, M., et al. (2001) Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immuno-deficiency virus-infected patients. Antimicrob Agents Chemother 45: 2676-2684.
54. Perfect, J.R. (1993) Antifungal prophylaxis: to prevent or not. Am J Med 94: 233-234.
55. Perfect, J.R., and Rude, T.H. (1993) Identifying Cryptococcus neoformans by differential expression at the site of infection. Abstract. L3, 24. 2nd International Conference on Cryptococcus and Cryptococcosis, Milan.
56. Pfaller, M., Zhang, J., Messer, S., Tumberland, M., Mbidde, E., Jessup, C., et al. (1998) Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients. Diagn Microbiol Infect Dis 32: 191-199.
57. Pfaller, M.A., Zhang, J., Messer, S.A., Brandt, M.E., Hajjeh, R.A., Jessup, C.J., et al. (1999) In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother 43: 169-171.
58. Powderly, W.G., Finkelstein, D., Feinberg, J., Frame, P., He, W., van der Horst, C., et al. (1995) A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med 332: 700-705.
59. Prasad, R., De Wergifosse, P., Goffeau, A., and Balzi, E. (1995) Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27: 320-329.
60. Reckseidler, S.L., DeShazer, D., Sokol, P.A., and Woods, D.E. (2001) Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun 69: 34-44.
61. Reiser, J., Glumoff, V., Ochsner, U.A., and Fiechter, A. (1994) Molecular analysis of the Trichosporon cutaneum DSM 70698 argA gene and its use for DNA-mediated transformations. J Bacteriol 176: 3021-3032.
62. Rex, J.H., Pfaller, M.A., Walsh, T.J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M.A., et al. (2001) Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 14: 643-658.
63. Saag, M.S., Graybill, R.J., Larsen, R.A., Pappas, P.G., Perfect, J.R., Powderly, W.G., et al. (2000) Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 30: 710-718.
64. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.L., Monod, M., and Bille, J. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39: 2378-2386.
65. Sanglard, D., Ischer, F., Monod, M., and Bille, J. (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416.
66. Sanglard, D., Ischer, F., Koymans, L., and Bille, J. (1998) Amino acid substitutions in the cytochrome P-450 lanosterol 14α-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 42: 241-253.
67. Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P.A., and Bille, J. (1999) The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 43: 2753-2765.
68. Servos, J., Haase, E., and Brendel, M. (1993) GeneSNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases. Mol Gen Genet 236: 214-218.
69. Seufert, W., Mcgrath, J.P., and Jentsch, S. (1990) UBC1 encodes a novel member of an essential subfamily of yeast ubiquitin-conjugating enzymes involved in protein degradation. EMBO J 9: 4535-4541.
70. Smits, P.H.M., de Hann, M., Maat, C., and Grivell, L.A. (1994) The complete sequence of a 33 kb fragment on the right arm of chromosome II from Saccharomyces cerevisiae reveals 16 open reading frames, five previously identified genes and a homologue of the SCO1 gene. Yeast 10: 75-80.
71. Sompayrac, L., Jane, S., Burn, T.C., Tenen, D.G., and Danna, K.J. (1995) Overcoming limitations of the mRNA differential display technique. Nucleic Acids Res 23: 4738-4739.
72. Soteropoulos, P., Vaz, T., Santangelo, R., Paderu, P., Huang, D.Y., Tamas, M.J., et al. (2000) Molecular characterization of the plasma membrane H (+)-ATPase, an anti-fungal target in Cryptococcus neoformans. Antimicrob Agents Chemother 44: 2349-2355.
73. Spitzer, S.G., and Spitzer, E.D. (1994) Characterization of the CNRE-1 family of repetitive DNA elements in Cryptococcus neoformans. Gene 144: 103-106.
74. Thornewell, S.J., Peery, R.B., and Skatrud, P.L. (1997) Cloning and characterization of CneMDR1: a Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins. Gene 201: 21-29.
75. Toffaletti, D.L., Rude, T.H., Johnston, S.A., Durack, D.T., and Perfect, J.R. (1993) Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol 175: 1405-1411.
76. Vanden Bossche, H., Marichal, P., and Odds, F.C. (1994) Molecular mechanisms of drug resistance in fungi. Trends Microbiol 2: 393-400.
77. Varma, A., and Kwon-Chung, K.J. (1999) Characterization of the glyceraldehyde-3-phosphate dehydrogenase gene and the use of its promoter for heterologous expression in Cryptococcus neoformans, a human pathogen. Gene 232: 155-163.
78. Venkateswarlu, K., Taylor, M., Manning, N.J., Rinaldi, M.G., and Kelly, S.L. (1997) Fluconazole tolerance in clinical isolates of Cryptococcus neoformans. Antimicrob Agents Chemother 41: 748-751.
79. Viard, J.P., Hennequin, C., Fortineau, N., Pertuiset, N., Rothschild, C., and Zylberberg, H. (1995) Fulminant cryptococcal infections in HIV-infected patients on oral fluconazole. Lancet 346: 118.
80. White, T.C. (1997a) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41: 1482-1487.
81. White, T.C. (1997b) The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14a demethylase in Candida albicans. Antimicrob Agents Chemother 41: 1488-1494.
82. White, T.C., Marr, K.A., and Bowden, R.A. (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11: 382-402.
83. Williamson, P.R., and Zhang, S. (1996) Transcriptional regulators of CNLAC1. Abstract. 1-4: 16-17. 3rd International Conference on Cryptococcus and Cryptococcosis, Paris.
84. Wills, E.A., Roberts, I.S., Del Poeta, M., Rivera, J., Casadevall, A., Cox, G.M., et al. (2001) Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity. Mol Microbiol 40: 610-620.
85. Xu, J., Onyewu, C., Yoell, H.J., Ali, R.Y., Vilgalys, R.J., and Mitchell, T.G. (2001) Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans. Antimicrob Agents Chemother 45: 420-427.
86. Zhang, Y.L., Ong, C.T., and Leung, K.Y. (2000) Molecular analysis of genetic differences between virulent and avirulent strains of Aeromonas hydrophila isolated from diseased fish. Microbiology 146: 999-1009.